Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

Clinical trial NCT06545916 · COMPLETED

Trial details

NCT number: NCT06545916
Sponsor: Knoa Pharma LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2024-10-14
Primary completion: 2026-05-05
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.